# Targeting the Mechanisms Underlying Cutaneous Neurofibroma Formation in NF1: A Clinical Translational Approach.

> **NCT02777775** · — · COMPLETED · sponsor: **Corewell Health West** · enrollment: 71 (actual)

## Conditions studied

- Cutaneous Neurofibromas
- Neurofibromatosis Type 1
- Plexiform Neurofibromas

## Interventions

- **PROCEDURE:** Skin Biopsy

## Key facts

- **NCT ID:** NCT02777775
- **Lead sponsor:** Corewell Health West
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-05
- **Primary completion:** 2025-06
- **Final completion:** 2025-06
- **Target enrollment:** 71 (ACTUAL)
- **Last updated:** 2025-07-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02777775

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02777775, "Targeting the Mechanisms Underlying Cutaneous Neurofibroma Formation in NF1: A Clinical Translational Approach.". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT02777775. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*